HK1216721A1 - 治療肝臟疾病或病狀的用途和方法 - Google Patents

治療肝臟疾病或病狀的用途和方法

Info

Publication number: HK1216721A1
Authority: HK; Hong Kong
Prior art keywords: treatment; conditions; methods; liver diseases; liver
Prior art date: 2012-12-21

Application number

HK16104784.4A

Other languages

English (en)

Inventor

Franois Ravenelle

Pierre Falardeau

Patrick Colin

Original Assignee

Verlyx Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-21

Filing date

2016-04-27

Publication date

2016-12-02

2016-04-27 Application filed by Verlyx Pharma Inc filed Critical Verlyx Pharma Inc

2016-12-02 Publication of HK1216721A1 publication Critical patent/HK1216721A1/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Molecular Biology (AREA)
Dermatology (AREA)

HK16104784.4A 2012-12-21 2016-04-27 治療肝臟疾病或病狀的用途和方法 HK1216721A1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261745011P	2012-12-21	2012-12-21
PCT/CA2013/051003 WO2014094176A1 (en)	2012-12-21	2013-12-20	Uses and methods for the treatment of liver diseases or conditions

Publications (1)

Publication Number	Publication Date
HK1216721A1 true HK1216721A1 (zh)	2016-12-02

Family

ID=50977490

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK16104784.4A HK1216721A1 (zh)	2012-12-21	2016-04-27	治療肝臟疾病或病狀的用途和方法

Country Status (12)

Country	Link
US (2)	US9375411B2 (zh)
EP (1)	EP2934501A4 (zh)
JP (1)	JP6370801B2 (zh)
KR (1)	KR20150126595A (zh)
CN (1)	CN104968340A (zh)
AU (1)	AU2013362755B2 (zh)
BR (1)	BR112015014836A2 (zh)
CA (1)	CA2894466A1 (zh)
HK (1)	HK1216721A1 (zh)
MX (1)	MX2015007945A (zh)
RU (1)	RU2015126505A (zh)
WO (1)	WO2014094176A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN111225686A (zh) *	2017-08-15	2020-06-02	普罗根尼蒂公司	使用可摄入装置释放免疫调节剂治疗炎性疾病
CN111448181B (zh) *	2017-11-16	2023-05-19	蒙特多力士有限公司	单脒和二脒核酸内切-外切酶抑制剂和抑制核酸内切-外切酶活性的方法
CN110478340A (zh) *	2018-05-14	2019-11-22	复旦大学	喷他嘧啶羟乙基磺酸盐在制备肝癌药物方面的应用
PH12022550330A1 (en)	2019-08-16	2023-02-06	Applied Molecular Transport Inc	Compositions, formulations, and interleukin production and purification

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA388674A (en) *		1940-05-14	The B. F. Goodrich Company	Brake structure
GB1288376A (zh)	1968-10-29	1972-09-06
DE2833135A1 (de)	1978-07-28	1980-02-07	Henkel Kgaa	Verwendung von substituierten oligocarbamidinen als mikrobistatika sowie diese enthaltende antimikrobielle mittel
US5204113A (en)	1987-04-09	1993-04-20	Fisons Plc	Pharmaceutical compositions containing pentamidine
US5084480A (en)	1987-11-06	1992-01-28	Fujisawa Usa, Inc.	Pentamidine salts useful in the treatment of pneumocystis carinii pneumonia
US4853416A (en)	1988-04-25	1989-08-01	Fisons Corporation	Solutions of pentamidine
US5162361A (en) *	1990-04-10	1992-11-10	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Method of treating diseases associated with elevated levels of interleukin 1
DE4321444A1 (de)	1993-06-28	1995-01-05	Bernd Prof Dr Clement	Pharmazeutische Zubereitung
JPH08333324A (ja)	1995-06-08	1996-12-17	Terumo Corp	ベンゼン誘導体およびそれを含有する医薬製剤
JP3540457B2 (ja)	1995-09-11	2004-07-07	テルモ株式会社	抗血栓性を賦与した医療用基材
OA11674A (en)	1998-11-10	2005-01-12	Janssen Pharmaceutica Nv	HIV Replication inhibiting pyrimidines.
US7884090B2 (en)	1999-03-17	2011-02-08	Ernest L. Bonner, Jr.	Compositions and methods for the treatment of arthritis
US7115665B1 (en)	2000-11-16	2006-10-03	Onocozyme Pharma, Inc.	Inhibitors of endo-exonuclease activity for treating cancer
US6569853B1 (en) *	2000-11-06	2003-05-27	Combinatorx, Incorporated	Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6693125B2 (en)	2001-01-24	2004-02-17	Combinatorx Incorporated	Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
EP1572070A4 (en)	2001-09-07	2009-11-04	Cleveland Clinic Foundation	THERAPEUTIC COMPOSITIONS AND METHOD FOR MODULATING PROTEIN TYROSINE PHOSPHATASES
US20040010045A1 (en)	2001-09-07	2004-01-15	Taolin Yi	Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
AU2003241346A1 (en) *	2002-05-01	2003-11-17	The Cleveland Clinic Foundation	Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
US20050054708A1 (en)	2003-07-28	2005-03-10	Nichols Matthew James	Combinations of drugs for the treatment of neoplasms
US7994225B2 (en)	2004-03-17	2011-08-09	Rempex Pharmaceuticals, Inc.	Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
WO2005089738A2 (en)	2004-03-17	2005-09-29	Mpex Pharmaceuticals, Inc.	Use and administration of bacterial efflux pump inhibitors
AU2005333545A1 (en)	2004-11-12	2007-01-04	Mediquest Therapeutics, Inc.	Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants
TW200719903A (en)	2005-04-19	2007-06-01	Combinatorx Inc	Compositions for the treatment of neoplasms
US7199267B1 (en)	2005-10-21	2007-04-03	Mediquest Therapeutics, Inc.	Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases
US20070197658A1 (en)	2006-02-22	2007-08-23	David Sunil A	Polyamines and their use as antibacterial and sensitizing agents
US20080226596A1 (en)	2006-06-19	2008-09-18	Taolin Yi	Therapeutic compositions and methods useful in treating hepatitis
DE102008007381A1 (de)	2008-02-01	2009-08-13	Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg	Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten
DE102008007426A1 (de)	2008-02-01	2009-08-06	Rheinische Friedrich-Wilhelms-Universität Bonn	Unbenetzbare Oberflächen
US8436049B2 (en)	2008-02-21	2013-05-07	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon	Uses of pentamidine and related compounds
WO2010125462A2 (en)	2009-05-01	2010-11-04	Oncozyme Pharma Inc.	Pentamidine combinations for treating cancer
US20120277193A1 (en)	2009-09-21	2012-11-01	President And Fellows Of Harvard College	Synergistic Combination Therapy
US20130244963A1 (en)	2010-09-30	2013-09-19	Portola Pharmaceuticals, Inc.	Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
PL2550963T3 (pl)	2011-07-25	2017-08-31	Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co. Kg	Estry kwasu amidooksymokarboksylowego pentamidyny jako proleki i ich zastosowanie jako leki
WO2014009592A1 (en) *	2012-07-11	2014-01-16	Waterbox Oy	Apparatus for providing rotating movement

2013
- 2013-12-20 CA CA2894466A patent/CA2894466A1/en not_active Abandoned
- 2013-12-20 AU AU2013362755A patent/AU2013362755B2/en not_active Ceased
- 2013-12-20 RU RU2015126505A patent/RU2015126505A/ru not_active Application Discontinuation
- 2013-12-20 CN CN201380067678.5A patent/CN104968340A/zh active Pending
- 2013-12-20 WO PCT/CA2013/051003 patent/WO2014094176A1/en active Application Filing
- 2013-12-20 EP EP13865316.7A patent/EP2934501A4/en not_active Withdrawn
- 2013-12-20 MX MX2015007945A patent/MX2015007945A/es unknown
- 2013-12-20 BR BR112015014836A patent/BR112015014836A2/pt not_active Application Discontinuation
- 2013-12-20 KR KR1020157019648A patent/KR20150126595A/ko active Search and Examination
- 2013-12-20 JP JP2015548129A patent/JP6370801B2/ja not_active Expired - Fee Related
- 2013-12-20 US US14/653,807 patent/US9375411B2/en not_active Expired - Fee Related
2016
- 2016-04-27 HK HK16104784.4A patent/HK1216721A1/zh unknown
- 2016-06-09 US US15/178,301 patent/US9827211B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU2013362755B2 (en)	2018-09-13
BR112015014836A2 (pt)	2017-07-11
US9827211B2 (en)	2017-11-28
US20150297540A1 (en)	2015-10-22
US20160287535A1 (en)	2016-10-06
CA2894466A1 (en)	2014-06-26
WO2014094176A1 (en)	2014-06-26
KR20150126595A (ko)	2015-11-12
MX2015007945A (es)	2016-02-16
JP2016503035A (ja)	2016-02-01
AU2013362755A1 (en)	2015-07-02
CN104968340A (zh)	2015-10-07
EP2934501A4 (en)	2016-06-01
RU2015126505A (ru)	2017-01-27
US9375411B2 (en)	2016-06-28
JP6370801B2 (ja)	2018-08-08
EP2934501A1 (en)	2015-10-28

Publication	Publication Date	Title
HUE041553T2 (hu)	2019-05-28	Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
HK1222552A1 (zh)	2017-07-07	索布替羅用於治療髓鞘形成疾病
IL239368A0 (en)	2015-07-30	Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
EP2890440A4 (en)	2016-06-08	DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DISEASES
EP2621499A4 (en)	2014-04-09	METHODS OF TREATING ALLERGIC DISEASES
EP2968318A4 (en)	2016-12-14	ANTI-PCSK9 COMPOUNDS AND METHODS FOR TREATING AND / OR PREVENTING CARDIOVASCULAR DISEASES
IL238177A0 (en)	2015-05-31	Methods and preparations for the treatment of cancer
HK1198909A1 (zh)	2015-06-19	用於治療肝臟疾病和障礙的組合物和方法
EP2852571A4 (en)	2015-11-25	COMPOSITIONS AND METHOD FOR THE TREATMENT OF MUCOSITIS
HRP20181879T1 (hr)	2019-02-08	Spojevi za liječenje pretilosti i postupci za njihovu upotrebu
HK1201045A1 (zh)	2015-08-21	用於腫瘤診斷和治療的組合物和方法
ZA201408055B (en)	2016-03-30	Compositions and methods for the treatment of local pain
HK1220374A1 (zh)	2017-05-05	用於治療碳氧血紅蛋白血症的組合物和方法
PL2892556T3 (pl)	2019-11-29	Kompozycje i sposoby odnoszące się do leczenia chorób
EP2709632A4 (en)	2015-03-04	COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
HK1202053A1 (zh)	2015-09-18	肝臟狀況的治療
AP2014007905A0 (en)	2014-08-31	Novel compounds for the treatment of dyslipidemia and related diseases
IL238592A0 (en)	2015-06-30	Methods for treating liver diseases
HK1216721A1 (zh)	2016-12-02	治療肝臟疾病或病狀的用途和方法
ZA201408062B (en)	2016-04-28	Compositions and methods for the treatment of multiple sclerosis
HK1218882A1 (zh)	2017-03-17	用於治療神經退化疾病和其它疾病的組合治療劑和方法
ZA201408065B (en)	2016-04-28	Compositions and methods for the treatment of diabetes
ZA201408058B (en)	2016-03-30	Compositions and methods for the treatment of epilepsy
EP3068431A4 (en)	2017-08-23	Methods and compositions for the treatment of hcmv
PL3079684T3 (pl)	2020-06-01	Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna